Musaffa Logo

MIRM Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Mirum Pharmaceuticals Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc. Stock Analysis MIRM

United States Health Care Mid Cap Report:
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Foster City, California and currently employs 369 full-time employees. The company went IPO on 2019-07-18. The firm is focused on the treatment of rare diseases affecting children and adults. The company has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States, Canada and Japan. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The firm is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.
Read More

Mirum Pharmaceuticals Inc (MIRM) Chart

Key Statistics of Mirum Pharmaceuticals Inc (MIRM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$116.01$118.75

Today's Open

$116.18

Volume

365.74K

P/E Ratio (TTM)

-

52 Week Range

$50.25$130.00

Market Cap

7.84B

Avg. Volume

925.13K

Dividend Yield

-

Financial Metrics & Statements of Mirum Pharmaceuticals Inc (MIRM)

Super Investors Invested in Mirum Pharmaceuticals Inc (MIRM)

FAQ's for Mirum Pharmaceuticals Inc (MIRM)

  • As of July 2026, Mirum Pharmaceuticals Inc MIRM is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mirum Pharmaceuticals Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Mirum Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Mirum Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Mirum Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Mirum Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.